Omega-3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder: A systematic review and meta-analysis of double-blind randomized, placebo-controlled trials

source extracted confidence: high 2026-04-09
#adult #bipolar-disorder #depression #disease-progression #double-blind-method

Omega-3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder: A systematic review and meta-analysis of double-blind randomized, placebo-controlled trials

Kishi et al., 2021 | Bipolar Disord | Meta Analysis

Citation

Kishi Taro, Sakuma Kenji, ... Iwata Nakao. Omega-3 fatty acids for treating residual depressive symptoms in adult patients with bipolar disorder: A systematic review and meta-analysis of double-blind randomized, placebo-controlled trials. Bipolar Disord. 2021-Nov;23(7):730-731. doi:10.1111/bdi.13115

Abstract

No abstract available

Key Findings

Requires manual extraction from full text

Outcomes Measured

  • Requires manual extraction

Population

Field Value
Population See abstract
Sample Size See abstract
Age Range See abstract
Condition See abstract

MeSH Terms

  • Adult
  • Bipolar Disorder
  • Depression
  • Disease Progression
  • Double-Blind Method
  • Fatty Acids, Omega-3
  • Humans
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Evidence Classification

  • Level: Meta Analysis
  • Publication Types: Letter, Meta-Analysis, Systematic Review
  • Vertical: omega-3-bipolar

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09